Analysts have clear opinions on COLL.
There are 8 analysts on the Wall offering 12 month price targets for Collegium Pharmaceutical in the last 3 months. The average price target is $29.00 with a high forecast of $36.00 and a low forecast of $22.00. The average price target represents a 20.33% increase from the last price of $24.10.
Collegium Pharmaceutical, Inc. (COLL) is followed by 8 analysts on the street.
Kevin Kedra from Gabelli rates it a Buy.
Similarly, 7 days ago Ed Arce of H.C. Wainwright Reiterated a Buy with a target of $29.00.
The consensus on the street is Strong Buy.
What does Collegium Pharmaceutical, Inc.(COLL) do ?
Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.
Collegium Pharmaceutical, Inc. (COLL) Insider Trades
Multiple company employees have indulged in significant insider trading. Collegium Pharmaceutical, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):
Dir, Hirsch David : S – Sale(-$483,250) of COLL in the trading session of 2019-11-08.
CTO Fleming Alison B : S – Sale+OE(-$486,000) of COLL in the trading session of 2019-11-08.
Pres, CEO Ciaffoni Joseph : S – Sale+OE(-$1,216,774) of Collegium Pharmaceutical, Inc. in the trading session of 2019-11-07.
Looking for stocks just like COLL?
Based on Wall Street analyst research, several stocks are similar to COLL
– BPMC [Info can be found here: https://www.nasdaq.com/market-activity/stocks/BPMC ]
– KMPH [Info can be found here: https://www.nasdaq.com/market-activity/stocks/KMPH ]
– CNCE [Info can be found here: https://www.nasdaq.com/market-activity/stocks/CNCE ]